Associate Professor
Department of Pharmacology
Upstate Medical University
USA
Education
PhD | 2001 | University of Tokyo, Japan |
Postdoctoral Fellow | 2005 | Harvard Medical School, USA |
Biography
Research Interest
Stem cell biology, cell signaling, hematopoiesis and blood cancer
Professional Activities:
- American Society of Hematology (ASH)
- American Association for Cancer Research (AACR)
Publications
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.
- Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
- The role of Shp2 (PTPN11) in cancer.
- Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer.
- Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.
- Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.
- Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
- Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.
- Critical role for Gab2 in transformation by BCR/ABL.
- Analysis of mechanisms involved in the prevention of gamma irradiation-induced apoptosis by hGM-CSF.
- Activation and functional analysis of Janus kinase 2 in BA/F3 cells using the coumermycin/gyrase B system.
- Monoclonal antibodies to the enterotoxin of Bacteroides fragilis: production, characterization, and immunodiagnostic application.
- Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.